Unmasking the microbiome: the hidden role of gut bacteria in the pathogenesis of colorectal cancer and its prevention strategies.

Q3 Medicine
Exploration of targeted anti-tumor therapy Pub Date : 2025-11-24 eCollection Date: 2025-01-01 DOI:10.37349/etat.2025.1002351
Tallha W Khawaja, Lei Zhao, Raiq Siddiq, Mohammad U Ahmad, Caitlin P Burns, Jacob M Parker, Mark R Wakefield, Yujiang Fang
{"title":"Unmasking the microbiome: the hidden role of gut bacteria in the pathogenesis of colorectal cancer and its prevention strategies.","authors":"Tallha W Khawaja, Lei Zhao, Raiq Siddiq, Mohammad U Ahmad, Caitlin P Burns, Jacob M Parker, Mark R Wakefield, Yujiang Fang","doi":"10.37349/etat.2025.1002351","DOIUrl":null,"url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a significant global health problem, ranking as the third most common cancer and the second leading cause of cancer deaths in the world. The highest incidence of CRC is found in developed regions, thus underlining its characterization as a Western disease. Major risk factors for CRC include an unhealthy diet, lack of physical exercise, and cigarette smoking. The gut microbiota refers to the complex community of microorganisms inhabiting the digestive tract and plays a crucial role in the maintenance of host health and modulation of immune responses. Gut dysbiosis can be caused by poor diet and alcohol consumption, increasing CRC risk. Specific bacteria, such as <i>Fusobacterium nucleatum</i> and <i>Escherichia coli</i>, may have a close relationship with CRC development, while the beneficial bacteria are frequently depleted in CRC patients. This paper will discuss the mechanisms of colorectal carcinogenesis, focusing on the effects of bacterial genotoxins, immune evasion, inflammation, and diet. Additionally, it reviews preventative strategies including short-chain fatty acids (SCFAs), prebiotics, probiotics, synbiotic supplements, and the method of fecal microbiota transplantation (FMT), showing their potential to improve overall gut health and reduce the risk for CRC. Understanding these mechanisms and implementing specific preventative strategies could significantly enhance clinical interventions and reduce the global burden of CRC.</p>","PeriodicalId":73002,"journal":{"name":"Exploration of targeted anti-tumor therapy","volume":"6 ","pages":"1002351"},"PeriodicalIF":0.0000,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12661407/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of targeted anti-tumor therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/etat.2025.1002351","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Colorectal cancer (CRC) is a significant global health problem, ranking as the third most common cancer and the second leading cause of cancer deaths in the world. The highest incidence of CRC is found in developed regions, thus underlining its characterization as a Western disease. Major risk factors for CRC include an unhealthy diet, lack of physical exercise, and cigarette smoking. The gut microbiota refers to the complex community of microorganisms inhabiting the digestive tract and plays a crucial role in the maintenance of host health and modulation of immune responses. Gut dysbiosis can be caused by poor diet and alcohol consumption, increasing CRC risk. Specific bacteria, such as Fusobacterium nucleatum and Escherichia coli, may have a close relationship with CRC development, while the beneficial bacteria are frequently depleted in CRC patients. This paper will discuss the mechanisms of colorectal carcinogenesis, focusing on the effects of bacterial genotoxins, immune evasion, inflammation, and diet. Additionally, it reviews preventative strategies including short-chain fatty acids (SCFAs), prebiotics, probiotics, synbiotic supplements, and the method of fecal microbiota transplantation (FMT), showing their potential to improve overall gut health and reduce the risk for CRC. Understanding these mechanisms and implementing specific preventative strategies could significantly enhance clinical interventions and reduce the global burden of CRC.

Abstract Image

Abstract Image

揭示微生物群:肠道细菌在结直肠癌发病机制中的隐藏作用及其预防策略。
结直肠癌(CRC)是一个重大的全球健康问题,是世界上第三大常见癌症和第二大癌症死亡原因。结直肠癌发病率最高的是发达地区,因此强调了其作为西方疾病的特征。结直肠癌的主要危险因素包括不健康的饮食、缺乏体育锻炼和吸烟。肠道菌群是指居住在消化道的复杂微生物群落,在维持宿主健康和调节免疫反应中起着至关重要的作用。不良饮食和饮酒可引起肠道生态失调,增加结直肠癌的风险。特定的细菌,如核梭杆菌和大肠杆菌,可能与结直肠癌的发展有密切的关系,而在结直肠癌患者中,有益细菌经常被耗尽。本文将讨论结直肠癌的发生机制,重点讨论细菌基因毒素、免疫逃避、炎症和饮食的影响。此外,它回顾了包括短链脂肪酸(SCFAs)、益生元、益生菌、合成补充剂和粪便微生物群移植(FMT)方法在内的预防策略,显示了它们改善整体肠道健康和降低结直肠癌风险的潜力。了解这些机制并实施具体的预防策略可以显著加强临床干预,减轻全球结直肠癌的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书